Interesting to note also that the clinic has a ‘check-in’ kiosk – don’t know where from though.
“One minute they are appointment booking and kiosks, next minute they are in medicinal cannabis services. They need to be really clear to the market as to what business they are in” (Doc4) It is clear to me, JHL are maximising the potential for their IP kiosk technology – a very smart move IMO. MediCann NZ has a wealth of expertise behind it, including medical and pharmaceutical based personnel. MediCann has the potential to move this company forward, especially in a medical sector (Medical Cannabis) that is going to be a major global force in the near future.
Connect the dots and lift your sights into the North American and European market place and you’ll soon see the potential for growth and profits. ‘Gypsy1234’ is spot on…”on the cusp or beginning of a full transformation”
The presentation is by Dr David (Dedi) Meiri Head of the "Laboratory of Cancer Biology and Cannabinoid Research", Technion, Israel Institute of Technology Israel.
Research into cannabis specific strains to treat specific illnesses has been on an exponential increase over the last six years, with no signs of any slowing down. This is confirmed by Dr Meiriwho claims we have only scratched the surface in exploring and testing the various applications and benefits of the 100+ known cannabinoids.
The abundance of ‘non-holders’ imparting their wisdom here is interesting, yet not surprising given the sudden turn in the Jayex business direction. There are at least 8+ posters here on JHL that get what is going on here. I guess it will only be a matter of time before others begin to see the potential for growth and profits as well.
JHL Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held